The vitamin "d-bate": What vascular risk in geriatric inpatients?

Journal of the American Geriatrics Society

Volumn 59, Issue 8, 2011, Pages 1556-1558

  Abraham, Paul S ^a   Calès, Sophie ^a   Redureau, Elise ^a   Fantino, Bruno ^a,b   De Decker, Laure ^c,d   Beauchet, Olivier ^a,b   Annweiler, Cédric ^a,b  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PARATHYROID HORMONE; VITAMIN D;

AFRICAN AMERICAN; AGED; AGED HOSPITAL PATIENT; ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; BODY MASS; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GERIATRIC CARE; HUMAN; HYPOVITAMINOSIS D; INTESTINE ABSORPTION; LETTER; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MEDIACALCOSIS; OXIDATIVE STRESS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRESCRIPTION; QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

25-HYDROXYVITAMIN D 2; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CALCINOSIS; CROSS-SECTIONAL STUDIES; FEMALE; FRAIL ELDERLY; HOSPITALIZATION; HUMANS; MALE; REFERENCE VALUES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80051777399     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03513.x     Document Type: Letter

References (10)

1. Melamed ML, Muntner P, Michos ED, et al,. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: Results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008; 28: 1179-1185.
2. Barnard K, Colon-Emeric C., Extraskeletal effects of vitamin D in older adults: Cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother 2010; 8: 4-33.
3. Freedman BI, Wagenknecht LE, Hairston KG, et al,. Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 2010; 95: 1076-1083.
4. Razzaque MS., The dualistic role of vitamin D in vascular calcifications. Kidney Int 2011; 79: 708-714.
5. Norgren L, Hiatt WR, Dormandy JA, et al,. Inter-Society Consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45: S5-S67. (Pubitemid 46151680)
6. Allison MA, Hiatt WR, Hirsch AT, et al,. A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life. J Am Coll Cardiol 2008; 51: 1292-1298. (Pubitemid 351400901)
7. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al,. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28. (Pubitemid 44699167)
8. Bas A, Lopez I, Perez J, et al,. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 2006; 21: 484-490.
9. Zebger-Gong H, Müller D, Diercke M, et al,. 1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: Up-regulation of osteoblast markers, calcium-transporting proteins and osterix. J Hypertens 2011; 29: 339-348.
10. Bolland MJ, Avenell A, Baron JA, et al,. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: Meta-analysis. BMJ 2010; 341: c3691. doi: DOI: 10.1136/bmj.c3691.